We are live on ! Find out more
VKH

Virtu KCG Holdings Portfolio holdings

AUM $3.6B
1-Year Est. Return 17.11%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+17.11%
3 Year Est. Return
+11.98%
5 Year Est. Return
10 Year Est. Return
AUM
$4.21B
AUM Growth
-$601M
Cap. Flow
-$755M
Cap. Flow %
-17.93%
Top 10 Hldgs %
35.17%
Holding
3,922
New
993
Increased
964
Reduced
1,040
Closed
886

Sector Composition

Rank Sector Weight
1 Financials 7.01%
2 Consumer Discretionary 5.48%
3 Technology 5.46%
4 Healthcare 5.28%
5 Industrials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRDF icon
2751
Cardiff Oncology
CRDF
$66.5M
$61K ﹤0.01%
190
-29
-13% -$10.6K
JRJC
2752
DELISTED
China Finance Online Co., Ltd.
JRJC
$61K ﹤0.01%
1,416
-1,178
-45% -$51.6K
DFBG
2753
DELISTED
Differential Brands Group Inc
DFBG
$61K ﹤0.01%
+10,932
New +$51.9K
ASM
2754
Avino Silver & Gold Mines
ASM
$934M
$60K ﹤0.01%
29,105
+17,119
+143% +$42.6K
GSV
2755
DELISTED
Gold Standard Ventures Corp.
GSV
$60K ﹤0.01%
23,707
-53,320
-69% -$116K
JASN
2756
DELISTED
Jason Industries, Inc.
JASN
$60K ﹤0.01%
+26,871
New +$74.4K
COOP
2757
DELISTED
Mr. Cooper
COOP
$59K ﹤0.01%
2,085
+547
+36% +$15.4K
OAKS
2758
DELISTED
Five Oaks Investment Corp.
OAKS
$59K ﹤0.01%
+10,375
New +$60.4K
CCLD icon
2759
CareCloud
CCLD
$104M
$58K ﹤0.01%
+62,145
New +$57.3K
ECT
2760
DELISTED
ECA Marcellus Trust 1 Interest
ECT
$57K ﹤0.01%
25,882
+849
+3% +$1.81K
CSBR icon
2761
Champions Oncology
CSBR
$74.5M
$56K ﹤0.01%
+33,533
New +$62.4K
ATHX
2762
DELISTED
Athersys, Inc. Common Stock
ATHX
$56K ﹤0.01%
1,052
-641
-38% -$33.1K
CALA
2763
DELISTED
Calithera Biosciences, Inc
CALA
$56K ﹤0.01%
+857
New +$55.2K
WG
2764
DELISTED
Willbros Group
WG
$56K ﹤0.01%
29,802
-27,957
-48% -$57.4K
FUEL
2765
DELISTED
Rocket Fuel Inc.
FUEL
$56K ﹤0.01%
21,088
+9,882
+88% +$26.3K
DXLG icon
2766
Destination XL Group
DXLG
$31.2M
$54K ﹤0.01%
+12,586
New +$61.4K
LITS
2767
Lite Strategy Inc
LITS
$32.8M
$54K ﹤0.01%
+1,534
New +$51.6K
NSPR icon
2768
InspireMD
NSPR
$30.4M
$54K ﹤0.01%
+1
New +$104K
RPRX
2769
DELISTED
Repros Therapeutics Inc.
RPRX
$54K ﹤0.01%
+25,975
New +$51.4K
BIOL
2770
DELISTED
Biolase, Inc.
BIOL
$53K ﹤0.01%
+2
New +$35.6K
FSI icon
2771
Flexible Solutions
FSI
$64.2M
$52K ﹤0.01%
+23,263
New +$42.2K
GRCE
2772
Grace Therapeutics
GRCE
$33.8M
$52K ﹤0.01%
+608
New +$45K
SNMX
2773
DELISTED
Senomyx, Inc.
SNMX
$52K ﹤0.01%
12,136
-32,680
-73% -$119K
SGLY icon
2774
Singularity Future Technology
SGLY
$4.69M
$51K ﹤0.01%
+56
New +$54.9K
EPE
2775
DELISTED
EP Energy Corporation
EPE
$51K ﹤0.01%
11,718
+143
+1% +$596

Similar funds

Virtu KCG Holdings's Q3 2016 Portfolio in Review

As of Q3 2016, Virtu KCG Holdings held 3,922 positions worth $4.21B, down 13% from $4.81B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Virtu KCG Holdings withdrew a net $755M in Q3 2016, closing 886 positions and reducing 1,040 holdings. Its most notable exit was ProShares Short S&P500, an estimated $25.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 7% of assets, up from 6.4% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Virtu KCG Holdings opened a new position in iShares AAA-A Rated Corporate Bond ETF worth $8.67M.

  • Virtu KCG Holdings's largest Q3 2016 buy was iShares AAA-A Rated Corporate Bond ETF: 161,468 shares worth $8.67M.
  • Virtu KCG Holdings added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $79.1M increase.
  • Virtu KCG Holdings's biggest Q3 2016 reduction was PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund, cutting an estimated $84M.
  • Virtu KCG Holdings fully exited ProShares Short S&P500 in Q3 2016, selling an estimated $25.2M.
  • Virtu KCG Holdings's ten largest holdings make up 35% of its $4.21B portfolio in Q3 2016.
  • Virtu KCG Holdings opened 993 new positions and closed 886 in Q3 2016.
  • Virtu KCG Holdings's portfolio value fell 13% quarter-over-quarter to $4.21B.

Based on Virtu KCG Holdings's 13F filing for Q3 2016, filed 10 Nov 2016.